| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |